Latest news, press releases, and SEC filings for Dermata Therapeutics, Inc. (DRMAW) https://caymanjournal.com/stock/DRMAW en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Wed, 29 Jul 2026 13:48:25 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 🧾 What This Document Is This is a **PRELIMINARY PROXY STATEMENT** (a "pre-proxy"). Think of it as a detailed "meeting agenda" and "voter guide" that Dermata Therapeutics is sending to its shareholders before their annual meeting. It’s preliminary, meaning the final details might be tweaked. Its j https://caymanjournal.com/stock/DRMAW/sec-filing/0001493152-26-015348 https://caymanjournal.com/stock/DRMAW/sec-filing/0001493152-26-015348 Tue, 07 Apr 2026 00:00:00 GMT SEC Filing